# Archean Chemical Industries share price today (Archean Chemical Industries Ltd, NSE: ACI)

> Archean Chemical Industries share price today: ₹439.90 at the NSE close on 3 November 2026, down 33.5% in a year. Archean Chemical Industries (NSE: ACI) is worth ₹5,434 crore, trades at a P/E of 54.4 and has closed between ₹439.90 and ₹634.60 over the past 52 weeks. > Archean Chemical Industries Ltd's results are improving, and its P/E is near the top of its own history, higher than 86% of past readings. ACI · Chemicals - Inorganic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/archean-chemical-industries-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹439.90 (−33.5% in a year)
- P/E: 54.4× (higher than 86% of the last 3.9 years)
- Revenue (Sep 2026): ₹297 Cr (+27.5% on a year ago)
- Profit (Sep 2026): ₹31.0 Cr (+6.9% on a year ago)
- Operating margin: 24.0% (−3.0 points on a year ago)
- ROCE: 7%, FY26
- ROIC: 4.2%, against a 12.0% cost of capital: −7.8 points

The main question: results are strong, and the P/E is higher than 86% of its own history. ## What is the Archean Chemical Industries share price today? Archean Chemical Industries Ltd's share price was ₹439.90 at the close on 3 November 2026. It has been falling for 22 weeks. That is 17.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹440 and ₹635, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 15 weeks running. Over the last 3.9 years the share price moved −18% while the NIFTY 500 moved +37%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 24 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Archean Chemical Industries this quarter? Two changes stood out: profit grew again in the September 2026 quarter and operating margin down 3 points on a year earlier. 1. Profit grew again in the September 2026 quarter Profit was ₹31 crore, +6.9% on a year earlier (₹29 crore), after 3 quarters of decline. 2. Operating margin down 3 points on a year earlier 24% in the September 2026 quarter, from 27%. ## What are Archean Chemical Industries' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Archean Chemical Industries reported revenue of ₹297 crore, up 27.5% from ₹233 crore a year earlier, and a profit of ₹31.0 crore, up 6.9% from ₹29.0 crore. ### Archean Chemical Industries results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹297 crore | ₹233 crore | +27.5% |
| Profit | ₹31.0 crore | ₹29.0 crore | +6.9% |
| Earnings per share | ₹2.60 | ₹2.36 | +10.2% |
| Operating margin | 24.0% | 27.0% | −3.0 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 3 August 2026, about April to June 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Archean Chemical Industries share price history? Archean Chemical Industries closed at ₹439.90 on 3 November 2026, down 33.5% from ₹661.55 a year earlier (31 October 2025) and down 15.0% over three years. Its highest weekly close since November 2022 was ₹801.20 on 23 August 2024. ### Archean Chemical Industries share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹478.45 | −8.1% |
| 1 month ago · 1 Oct 2026 | ₹475.05 | −7.4% |
| 6 months ago · 30 Apr 2026 | ₹607.30 | −27.6% |
| 1 year ago · 31 Oct 2025 | ₹661.55 | −33.5% |
| 3 years ago · 3 Nov 2023 | ₹517.30 | −15.0% |
| Earliest weekly close in our records · 25 Nov 2022 | ₹534.00 | −17.6% |
| Highest weekly close since November 2022 · 23 Aug 2024 | ₹801.20 | −45.1% |
| Lowest weekly close since November 2022 · 14 Feb 2025 | ₹424.60 | +3.6% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹634.60 | −30.7% |
| 52-week low (weekly close) · 3 Nov 2026 | ₹439.90 | 0.0% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (212 weekly closes from 25 November 2022 to 3 November 2026.)

## What is the latest news on Archean Chemical Industries? 3 Nov 2026: Archean Chemical Industries closed at ₹439.90, down 8.1% on the week and down 7.4% on the month. Results for July to September 2026: Revenue up 27.5% and profit up 6.9% on a year earlier. ### Earlier

- 3 Aug 2026: Archean Chemical Industries held its results call for April to June 2026. Management guided: Bromine exit FY27 run rate of 20,000-25,000 tons, with FY28 full-year output planned around the same level. - 5 Jun 2026: ex-date for a dividend of ₹2.50 a share. ## What dividend does Archean Chemical Industries pay? Archean Chemical Industries paid ₹2.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.57% at the ₹439.90 close on 3 November 2026. The last was a dividend of ₹2.50 a share, ex-date 5 June 2026. ### Archean Chemical Industries dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 5 Jun 2026 | ₹2.50 | Dividend |
| 26 May 2025 | ₹3 | Dividend |
| 21 Jun 2024 | ₹1 | Dividend |
| 14 Feb 2024 | ₹1 | Interim |
| 17 Nov 2023 | ₹1 | Interim |
| 21 Jul 2023 | ₹2.50 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 3 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Archean Chemical Industries Ltd paid out 29% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 6 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Archean Chemical Industries management say on the latest results call? On the call for April to June 2026, held on 3 August 2026, Archean Chemical Industries' management guided: Bromine exit FY27 run rate of 20,000-25,000 tons, with FY28 full-year output planned around the same level. > “At a headline level, a large part of this cost increase will be mitigated as the reset happens. As fuel prices come down and routes are reset, this is not a structural cost increase.”
> Ranjit, on the call for April to June 2026

### What management guided

- Bromine realization near ₹300 per kg and most implemented price increases retained through FY27. - Highway work to finish by end September; salt volumes normalize from Q3 and deliver double-digit growth thereafter. - SOP phase-two trials by December and scale-up complete by year-end; full-year throughput of 9,000-10,000 tons. - ACUM derivatives to scale beyond break-even as utilization and organic mix build; oilfield chemicals to produce meaningful PAC and starch volumes in H2 and bentonite by year-end. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/47661/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 3 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Archean Chemical Industries' next results? When Archean Chemical Industries reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Salt dispatches and freight costs to normalize after highway completion; check whether recovery starts as management expects. - What to check (from the call)
- Salt dispatches and freight costs to normalize after highway completion; check whether recovery starts as management expects. - Bromine debottlenecking to lift output through the next two quarters; check sustained production rather than a one-quarter rebound. - ACUM margin contribution after break-even; check whether mix and utilization continue improving. - SiCSem approvals and construction start; check the project crosses from schedule commentary into physical execution. ## Which stock lists is Archean Chemical Industries on? Archean Chemical Industries is on one of our India lists: 52 week high & low. [52 week high & low 52-week position: At 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)

## Is Archean Chemical Industries profitable? Archean Chemical Industries Ltd earned ₹31.0 Cr of net profit in the Sep 2026 quarter, +6.9% on the same quarter a year earlier. Full-year FY26 profit was ₹105 Cr. That is 10.4% of the quarter's revenue. The same quarter a year earlier earned ₹29.0 Cr. For the full year, FY26 profit was ₹105 Cr (−35.2% on the year before). Why profit moved: revenue changed +27.5% on a year earlier and the margin moved −3.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −36.5% and revenue +8.0%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Archean Chemical Industries make, and is it growing? Archean Chemical Industries Ltd reported ₹297 Cr of revenue in the Sep 2026 quarter, +27.5% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 10.1% a year on average. The last full year, FY26, came in at ₹1,081 Cr. The last four reported quarters add to ₹1,180 Cr. FY26 revenue was ₹1,081 Cr, +3.8% on the year before. Recent pace: the last four quarters grew +8.0% on average, against 10.1% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +6.0%, against +1.3% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −43.3%, against −33.7% a year (rolling over). ## How much of every ₹100 of sales does Archean Chemical Industries keep? Archean Chemical Industries Ltd's operating margin was 24.0% in the Sep 2026 quarter, 3.0 percentage points lower than the same quarter a year ago. Across 6 years it has been between 22.0% and 44.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −3.2 percentage points on the year while gross margin changed −7.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Archean Chemical Industries' profit turning into cash? Over the last 3 years, 119% of Archean Chemical Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹140 Cr of operating cash against ₹105 Cr of profit. After ₹211 Cr of spending on assets, free cash was −₹71.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Archean Chemical Industries' cash go? Archean Chemical Industries Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹1,081 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹661 Cr on assets over the last 3 years. Averaged over those years that is 20.4% of FY26 revenue a year. Spending on assets: ₹661 Cr over the last 3 years, against ₹242 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹182 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Archean Chemical Industries' P/E ratio, and how does it compare with its own history? Archean Chemical Industries Ltd's P/E is 54.4×, near the high end of its own history: higher than 86% of past readings. Its usual P/E (the middle reading) is 36.1×, over 3.9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −34.1% while the price moved −33.5%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved −5.3% a year; about −36.6% a year came from earnings growth and about +31.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Archean Chemical Industries business getting better or worse? Archean Chemical Industries Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −43.3% in the latest quarter, against +21.6% at its best in 12 quarters, with ROCE falling at 7.1%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Archean Chemical Industries earn on its capital? Archean Chemical Industries Ltd earned a ROCE of 7% in FY26. Its return on capital used (ROIC) is 7.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 9.7% net margin and 0.41× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 9.7% net margin × 0.41× asset turnover × 1.38× leverage (assets divided by equity) ≈ 5.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 4.2% − 12.0% = −7.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Archean Chemical Industries have too much debt? Archean Chemical Industries Ltd has total debt of ₹551 Cr against shareholder equity of ₹1,961 Cr as of Sep 2026, so its debt is 0.28× its equity, which is very little. Year by year, that ratio went from 12.58 in FY21 to 0.24 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Archean Chemical Industries shareholding pattern? No group of Archean Chemical Industries Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.2 points over the same period, to 10.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −0.7 points over 8 quarters, to 21.3%; Foreign institutions: +0.2 points over 8 quarters, to 10.4%; Promoters: +0.0 points over 8 quarters, to 53.4%. ## How far is Archean Chemical Industries from balance-sheet trouble? For Archean Chemical Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Archean Chemical Industries rank in its industry? 29.8 out of 100, rank 8 of 9 in Chemicals - Inorganic, with 90% of the evidence available. Archean Chemical Industries Ltd scores 29.8 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 8. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 6.9 + 9.6 + 8.5 + 4.8 = 29.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Archean Chemical Industries compared with? Archean Chemical Industries ranks 8 of 9 Chemicals - Inorganic companies on the 4-Factor Sector Score, with 29.8 out of 100. 1. [Deepak Nitrite Ltd](https://www.sectoralpha.in/stocks/deepak-nitrite-ltd) DEEPAKNTR · quiet · Most evidence points up · 100% evidence 70.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 23.8% · Profit 100% · Operating margin change 9 points · 100% evidence Capital efficiency 12.4/25 · ROCE 11.4% · Operating margin 20% · 100% evidence Valuation 15.6/20 · P/E 19.4× · PEG 0.89 · 100% evidence Relative strength 9.3/20 · Lead over its industry -6.1% · Lead over NIFTY 500 -1.7% · 1 year -12.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 12.4 + 15.6 + 9.3 = 70 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) INDOBORAX · leader · Evidence leans up · 96% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 28.9% · Profit 47.4% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 15.4% · Operating margin 28% · 100% evidence Valuation 4.4/20 · P/E 25.5× · PEG 1.77 · 100% evidence Relative strength 11.8/20 · Lead over its industry 19.3% · Lead over NIFTY 500 22.2% · 1 year 44% · 100% evidence · 11 of 12 weeks ahead Exact sum: 24.8 + 18.6 + 4.4 + 11.8 = 59.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Ganesh Benzoplast Ltd](https://www.sectoralpha.in/stocks/ganesh-benzoplast-ltd) GANESHBE · losing its lead · Evidence leans up · 74% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 13.1% · Profit 87.2% · Operating margin change -7 points · 88% evidence Capital efficiency 11.2/25 · ROCE 14.5% · Operating margin 23% · 100% evidence Valuation 16.1/20 · P/E 9.7× · PEG 0.25 · 65% evidence Relative strength 8.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -3.7% · 1 year 1.9% · 25% evidence · 9 of 12 weeks ahead Exact sum: 21.1 + 11.2 + 16.1 + 8.7 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Tanfac Industries Ltd](https://www.sectoralpha.in/stocks/tanfac-industries-ltd) TANFACIND · leader · Evidence leans up · 76% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 13.2% · Profit -29.2% · Operating margin change -1 points · 83% evidence Capital efficiency 16.5/25 · ROCE 23.9% · Operating margin 15% · 95% evidence Valuation 8.5/20 · P/E 112× · PEG n/a · 15% evidence Relative strength 20.0/20 · Lead over its industry 44.2% · Lead over NIFTY 500 48.6% · 1 year 82.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 12 + 16.5 + 8.5 + 20 = 57 · What this means: Relative strength against the index is 48.6%, and revenue and profit growth are weak. 5. [J.G.Chemicals Ltd](https://www.sectoralpha.in/stocks/jgchemicals-ltd) JGCHEM · leader · Evidence leans up · 63% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 24% · Profit 16.4% · Operating margin change 2 points · 83% evidence Capital efficiency 15.5/25 · ROCE 17.7% · Operating margin 11% · 76% evidence Valuation 7.5/20 · P/E 29.3× · PEG n/a · 50% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 33.3% · 1 year 31.2% · 25% evidence · 12 of 12 weeks ahead Exact sum: 21.9 + 15.5 + 7.5 + 12 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) SRHHYPOLTD · breaking out · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.5/35 · Revenue 7.6% · Profit 1.1% · Operating margin change -1 points · 88% evidence Capital efficiency 12.9/25 · ROCE 13.7% · Operating margin 14% · 100% evidence Valuation 12.9/20 · P/E 8.4× · PEG 1.29 · 100% evidence Relative strength 10.7/20 · Lead over its industry n/a · Lead over NIFTY 500 2.9% · 1 year -12.1% · 25% evidence · 8 of 12 weeks ahead Exact sum: 15.5 + 12.9 + 12.9 + 10.7 = 52 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [POCL Enterprises Ltd](https://www.sectoralpha.in/stocks/pocl-enterprises-ltd) POEL · Evidence leans down · 69% evidence 46.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.8/43.75 · Revenue 4.6% · Profit -2% · Operating margin change -3 points · 88% evidence Capital efficiency 19.8/31.25 · ROCE 26.6% · Operating margin 2.5% · 100% evidence Valuation 18.4/25 · P/E 12.2× · PEG 0.71 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 7.8 + 19.8 + 18.4 = 46 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 8. Archean Chemical Industries Ltd this page ACI · quiet · Most evidence points down · 90% evidence 29.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.9/35 · Revenue 6% · Profit -43.3% · Operating margin change -3 points · 100% evidence Capital efficiency 9.6/25 · ROCE 7.4% · Operating margin 24% · 100% evidence Valuation 8.5/20 · P/E 54.7× · PEG n/a · 50% evidence Relative strength 4.8/20 · Lead over its industry -18.3% · Lead over NIFTY 500 -14% · 1 year -33.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 6.9 + 9.6 + 8.5 + 4.8 = 29.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) FISCHER · quiet · Most evidence points down · 71% evidence 26.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 39.1% · Profit -80% · Operating margin change -269.5 points · 65% evidence Capital efficiency 1.8/25 · ROCE -1.6% · Operating margin -261.1% · 100% evidence Valuation 8.9/20 · P/E 58.4× · PEG n/a · 15% evidence Relative strength 1.7/20 · Lead over its industry -36.8% · Lead over NIFTY 500 -33.5% · 1 year -79% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.2 + 1.8 + 8.9 + 1.7 = 26.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Inorganic](https://www.sectoralpha.in/sectors/chemicals-inorganic), all 9 compared on one page. ## Which companies are close to Archean Chemical Industries in size? Archean Chemical Industries is the 3rd largest of 9 Chemicals - Inorganic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Deepak Nitrite and Tanfac Industries. Just below it: J.G.Chemicals, Fischer Medical Ventures, Indo Borax & Chemicals and Sree Rayalaseema Hi-Strength Hypo. ### Chemicals - Inorganic companies close in size

1. [Deepak Nitrite Ltd](https://www.sectoralpha.in/stocks/deepak-nitrite-ltd) ₹20,724 crore
2. [Tanfac Industries Ltd](https://www.sectoralpha.in/stocks/tanfac-industries-ltd) ₹7,571 crore
3. Archean Chemical Industries Ltd ₹5,460 crore
4. [J.G.Chemicals Ltd](https://www.sectoralpha.in/stocks/jgchemicals-ltd) ₹2,204 crore
5. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) ₹1,732 crore
6. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) ₹1,248 crore
7. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) ₹833 crore

[All 9 Chemicals - Inorganic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-inorganic#all-companies)

### Companies close in size in other industries

1. [Wheels India Ltd](https://www.sectoralpha.in/stocks/wheels-india-ltd) ₹5,473 crore · Auto Ancillaries - Wheels
2. [GMM Pfaudler Ltd](https://www.sectoralpha.in/stocks/gmm-pfaudler-ltd) ₹5,464 crore · Glass - Others
3. Archean Chemical Industries Ltd ₹5,460 crore
4. [Man Industries (India) Ltd](https://www.sectoralpha.in/stocks/man-industries-indialtd) ₹5,443 crore · Steel - Tubes/Pipes
5. [Lohia Corp Ltd](https://www.sectoralpha.in/stocks/lohia-corp-ltd) ₹5,419 crore · Textile machinery

## What else do people ask about Archean Chemical Industries? ### What is Archean Chemical Industries's share price today? Archean Chemical Industries Ltd's share price is ₹439.90, −33.5% over the past year. The whole company is worth ₹5,434 Cr on the market. It is at its lowest price of the past 52 weeks (range ₹440 to ₹635), 17.0% below its 200-day average. The price has been falling for 22 weeks (as of 3 November 2026). ### What were Archean Chemical Industries's latest quarterly results? Archean Chemical Industries Ltd reported revenue of ₹297 Cr and net profit of ₹31.0 Cr for the Sep 2026 quarter. Revenue rose 27.5% and profit rose 6.9% compared with a year earlier. Earnings per share were ₹2.60. The operating margin was 24.0%, 3.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Archean Chemical Industries's market cap? Archean Chemical Industries Ltd's market capitalisation is ₹5,434 Cr at a share price of ₹439.90. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Archean Chemical Industries performing? Archean Chemical Industries Ltd's share price has been falling for 22 weeks. In its latest quarter, revenue rose 27.5% and profit rose 6.9% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 15 weeks running (as of 3 November 2026). ### Will Archean Chemical Industries's share price go up? This page does not forecast Archean Chemical Industries Ltd's share price. What it shows instead: the share price is ₹439.90, and it has been falling for 22 weeks. Its P/E of 54.4× is higher than 86% of its own last 4 years (as of 3 November 2026). ### Who owns Archean Chemical Industries? Promoters own 53.4% of Archean Chemical Industries Ltd, foreign institutions 10.4%, domestic institutions 21.3% and the public 14.8% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Does Archean Chemical Industries have too much debt? No, Archean Chemical Industries Ltd has little debt: its debt is 0.24× its equity, and its operating profit is 9 times its interest bill. FY26 borrowings were ₹466 Cr against equity of ₹1,935 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Archean Chemical Industries in its business cycle? Archean Chemical Industries Ltd's FY26 operating margin was 22.0%, against a 6-year range of 22.0% to 44.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 24.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Archean Chemical Industries story? The main question: results are strong, and the P/E is higher than 86% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Archean Chemical Industries a stock worth studying right now? What the numbers show: Archean Chemical Industries Ltd's results are improving, and its P/E is near the top of its own history, higher than 86% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Archean Chemical Industries share price forecast for 2026? What management itself guided: Bromine exit FY27 run rate of 20,000-25,000 tons, with FY28 full-year output planned around the same level. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india

This is research, not advice. We’re not SEBI-registered.